Your Patient Can't Find Their Aimovig — Here's How to Help

When a migraine patient finally responds to Aimovig (Erenumab-aooe), the last thing either of you wants is a gap in treatment because the pharmacy can't fill the prescription. But it happens — and it happens more often than it should.

As a prescriber, you're in a unique position to prevent these access problems before they start and resolve them quickly when they occur. This guide offers practical, actionable steps for helping your patients maintain uninterrupted access to Aimovig in 2026.

Current Availability: What's Actually Going On

Aimovig is not in a formal shortage as of early 2026. Amgen continues to manufacture and distribute the medication, and it's not listed on the FDA Drug Shortage Database.

However, patients frequently report difficulty filling their prescriptions. The primary causes are:

• Retail pharmacies don't stock it. Aimovig is a specialty biologic requiring cold-chain storage. Most retail pharmacies (CVS, Walgreens, independent pharmacies) do not carry it on their shelves.
• Insurance barriers. Prior authorization delays, step therapy requirements, and formulary exclusions create administrative obstacles that prevent or delay fills.
• Specialty pharmacy transitions. When patients change insurance plans or when PBMs switch preferred specialty pharmacies, existing fulfillment arrangements can break.
• No biosimilar. With Amgen as the sole manufacturer and no biosimilar competition, there's no alternative product to fall back on within the same formulation.

Why Patients Can't Find Aimovig (And What They Tell You vs. What's Actually Happening)

Patients often say "my pharmacy doesn't have it" or "it's out of stock." But when you dig deeper, the issue usually falls into one of these categories:

• "We don't carry it" — Pharmacy doesn't stock specialty biologics. Solution: Route to a specialty pharmacy.
• "Your insurance denied it" — Prior auth expired, wasn't submitted, or was rejected. Solution: Resubmit PA with updated documentation.
• "We need to order it" — Pharmacy can get it but doesn't keep it in stock. Solution: Patient needs to plan refills 1-2 weeks ahead.
• "You need to use a different pharmacy" — Insurance PBM requires a specific specialty pharmacy. Solution: Identify the required pharmacy and transfer the prescription.

Helping your staff understand these distinctions can dramatically reduce the time spent troubleshooting patient calls.

Five Steps to Help Your Patients Get Aimovig

Step 1: Verify Formulary Status Before Prescribing

Before writing the prescription, check whether Aimovig is on your patient's formulary — and whether it's preferred or non-preferred. If another CGRP inhibitor (Ajovy, Emgality, Vyepti, or Qulipta) is preferred, prescribing the preferred agent first can save weeks of back-and-forth.

Many EHR systems have integrated formulary lookup tools. If yours doesn't, payer-specific formulary PDFs are typically available online, or your staff can call the PBM's provider line.

Step 2: Submit Prior Authorization Proactively

Don't wait for a pharmacy rejection to trigger the PA process. Submit the prior authorization at the time of prescribing — or even before the patient's current PA expires.

Common PA requirements for Aimovig include:

• Documented diagnosis of episodic or chronic migraine
• Documentation of migraine frequency (headache days per month)
• Trial and failure of 2-3 preventive medications (typically Topiramate, a beta-blocker, and/or an antidepressant)
• For renewals: documentation of clinical benefit (e.g., ≥30% reduction in migraine frequency)

Amgen provides prior authorization checklists and appeal templates that your staff can use to streamline the process.

Step 3: Direct Patients to the Right Pharmacy

Ensure the prescription is sent to a specialty pharmacy — not a retail pharmacy. Common specialty pharmacies that carry Aimovig include:

• Accredo (Express Scripts)
• CVS Specialty
• OptumRx Specialty
• AllianceRx Walgreens Pharmacy
• Biologics by McKesson

If you're unsure which specialty pharmacy your patient's plan uses, your staff can check with the PBM or have the patient call their insurer.

Step 4: Connect Patients with Support Resources

Make sure patients know about these programs:

• Aimovig Co-Pay Card: Commercially insured patients may pay as little as $5/month. Sign up at aimovigcopaycard.com.
• Amgen Safety Net Foundation: Free Aimovig for eligible uninsured/underinsured patients.
• Amgen SupportPlus: End-to-end support for insurance navigation, pharmacy coordination, and financial assistance. 1-888-4AIMOVIG (1-888-424-6684).
• Medfinder for Providers: Check pharmacy availability for Aimovig and other medications.

Step 5: Have a Backup Plan Ready

If Aimovig access fails despite your best efforts, be prepared to pivot quickly. Having a pre-discussed alternative reduces the time your patient goes without preventive treatment:

• Ajovy (Fremanezumab): Monthly or quarterly subcutaneous injection. Targets CGRP ligand.
• Emgality (Galcanezumab): Monthly subcutaneous injection. Also approved for episodic cluster headache.
• Vyepti (Eptinezumab): Quarterly IV infusion. Administered in-office — may be easier for patients struggling with pharmacy logistics.
• Qulipta (Atogepant): Daily oral pill. Avoids injection and specialty pharmacy channels entirely.

Document the clinical rationale for any switch in case the patient's insurer requires justification. For detailed comparison, see alternatives to Aimovig.

Workflow Tips for Your Practice

Standardize PA Tracking

Create a system (spreadsheet, EHR task list, or PA tracking software) to monitor prior authorization expiration dates for all patients on CGRP inhibitors. Proactively renew PAs at least 30 days before expiration.

Designate a Specialty Pharmacy Point Person

Having one staff member who understands the specialty pharmacy landscape — who to call, how to transfer prescriptions, and how each PBM's system works — can dramatically reduce access delays across your entire patient panel.

Educate Patients at the First Prescription

When you first prescribe Aimovig, set expectations:

• Explain that it's filled through a specialty pharmacy, not their regular pharmacy
• Tell them to reorder 1-2 weeks before their next dose
• Provide the Amgen SupportPlus phone number
• Mention the copay card or patient assistance program if applicable

A few minutes of upfront education can prevent hours of downstream frustration — for your patient and your staff.

Monitor for Access Red Flags

If multiple patients report access issues in a short timeframe, it may indicate a PBM formulary change, a specialty pharmacy transition, or a localized distribution issue. Reaching out to your Amgen representative can provide clarity.

Final Thoughts

Aimovig access problems in 2026 are systemic, not supply-driven. The medication exists — it's the path from manufacturer to patient that breaks down. As providers, we can significantly reduce these breakdowns by prescribing with formulary awareness, submitting PAs proactively, routing prescriptions to the right pharmacies, and connecting patients with support resources.

For real-time pharmacy availability, visit Medfinder for Providers. For the patient-facing version of this guidance, share our article on how to find Aimovig in stock.